|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.960 EUR | +1.13% |
|
+2.63% | -37.34% |
| 06-08 | Intrasense and Guerbet Obtain PMDA Certification In Japan For DUOnco Pancreas AI Software | CI |
| 06-08 | Guerbet and Intrasense secure landmark regulatory approval in Japan |  |
Company Valuation: Guerbet
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 469.8 | 214.1 | 246.1 | 337.9 | 180.2 | 113 | - | - |
| Change | - | -54.42% | 14.95% | 37.29% | -46.68% | -37.27% | - | - |
| Enterprise Value (EV) 1 | 687.6 | 484.5 | 581.9 | 682.8 | 505.9 | 406.6 | 390.4 | 403.6 |
| Change | - | -29.54% | 20.1% | 17.33% | -25.91% | -19.64% | -3.98% | 3.39% |
| P/E | 14.5x | -5.22x | 11.1x | 25x | -1.6x | -252x | 5.57x | 5.12x |
| PBR | 1.16x | 0.56x | 0.65x | 0.86x | 0.68x | 0.34x | 0.32x | 0.31x |
| PEG | - | 0x | -0x | -0.6x | 0x | 2.5x | -0x | 0.58x |
| Capitalization / Revenue | 0.64x | 0.28x | 0.31x | 0.4x | 0.23x | 0.15x | 0.14x | 0.14x |
| EV / Revenue | 0.94x | 0.64x | 0.74x | 0.81x | 0.64x | 0.54x | 0.49x | 0.49x |
| EV / EBITDA | 6.54x | 4.7x | 5.89x | 5.72x | 6.15x | 4.6x | 3.23x | 3.38x |
| EV / EBIT | 17.8x | -26.6x | 15x | 13.8x | -5.74x | 16.4x | 6.96x | 7.77x |
| EV / FCF | 11.5x | -13.1x | -8.9x | 28.2x | 17.5x | 10.9x | 10.5x | 7.37x |
| FCF Yield | 8.67% | -7.66% | -11.2% | 3.55% | 5.71% | 9.2% | 9.55% | 13.6% |
| Dividend per Share 2 | 0.85 | 0.5 | 0.5 | - | - | - | 0.35 | 0.24 |
| Rate of return | 2.28% | 2.95% | 2.56% | - | - | - | 3.91% | 2.68% |
| EPS 2 | 2.58 | -3.25 | 1.75 | 1.07 | -8.91 | -0.0356 | 1.609 | 1.75 |
| Distribution rate | 32.9% | -15.4% | 28.6% | - | - | - | 21.8% | 13.7% |
| Net sales 1 | 732.1 | 753.3 | 785.7 | 841.1 | 786.4 | 753.8 | 796.2 | 830.8 |
| EBITDA 1 | 105.1 | 103.1 | 98.8 | 119.4 | 82.3 | 88.41 | 120.7 | 119.4 |
| EBIT 1 | 38.7 | -18.2 | 38.7 | 49.6 | -88.2 | 24.86 | 56.05 | 51.96 |
| Net income 1 | 32.6 | -41.1 | 22.2 | 13.5 | -112.7 | -1.617 | 29.08 | 27.6 |
| Net Debt 1 | 217.8 | 270.4 | 335.8 | 344.9 | 325.7 | 293.5 | 277.4 | 290.6 |
| Reference price 2 | 37.300 | 16.960 | 19.500 | 26.800 | 14.300 | 8.960 | 8.960 | 8.960 |
| Nbr of stocks (in thousands) | 12,596 | 12,625 | 12,622 | 12,609 | 12,601 | 12,615 | - | - |
| Announcement Date | 3/23/22 | 3/22/23 | 3/20/24 | 3/26/25 | 3/11/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -251.76x | 0.54x | 4.6x | -.--% | 129M | |
| 39.25x | 5.04x | 28.43x | 0.32% | 13.35B | |
| 30.97x | 7.86x | 23.49x | 1.06% | 3.86B | |
| 50.8x | - | - | - | 1.24B | |
| 22.56x | 2.59x | 19.26x | 1.28% | 1.18B | |
| -12.9x | - | - | - | 335M | |
| Average | -20.18x | 4.01x | 18.94x | 0.67% | 3.35B | |
| Weighted average by Cap. | 34.65x | 5.44x | 26.65x | 0.53% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GBT Stock
- Valuation Guerbet
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
